|
Name |
Thiocladospolide J
|
| Molecular Formula | C27H42O10S | |
| IUPAC Name* |
[(2R,8S)-8-hydroxy-8-[(2S)-5-oxo-2H-furan-2-yl]octan-2-yl] (2S)-2-hydroxy-3-[[(3S,6S,12R)-6-hydroxy-12-methyl-2,5-dioxo-oxacyclododec-3-yl]sulfanyl]propanoate
|
|
| SMILES |
C[C@@H]1CCCCC[C@@H](C(=O)C[C@@H](C(=O)O1)SC[C@H](C(=O)O[C@H](C)CCCCC[C@@H]([C@@H]2C=CC(=O)O2)O)O)O
|
|
| InChI |
InChI=1S/C27H42O10S/c1-17(9-6-4-8-12-20(29)23-13-14-25(32)37-23)35-26(33)22(31)16-38-24-15-21(30)19(28)11-7-3-5-10-18(2)36-27(24)34/h13-14,17-20,22-24,28-29,31H,3-12,15-16H2,1-2H3/t17-,18-,19+,20+,22-,23+,24+/m1/s1
|
|
| InChIKey |
KPILJRSNGLXCKI-VJDUZYELSA-N
|
|
| Synonyms |
Thiocladospolide J
|
|
| CAS | NA | |
| PubChem CID | 156582699 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 558.7 | ALogp: | 3.2 |
| HBD: | 3 | HBA: | 11 |
| Rotatable Bonds: | 13 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 182.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 38 | QED Weighted: | 0.184 |
| Caco-2 Permeability: | -5.386 | MDCK Permeability: | 0.00000889 |
| Pgp-inhibitor: | 0.317 | Pgp-substrate: | 0.995 |
| Human Intestinal Absorption (HIA): | 0.079 | 20% Bioavailability (F20%): | 0.961 |
| 30% Bioavailability (F30%): | 0.918 |
| Blood-Brain-Barrier Penetration (BBB): | 0.109 | Plasma Protein Binding (PPB): | 93.36% |
| Volume Distribution (VD): | 1.045 | Fu: | 4.84% |
| CYP1A2-inhibitor: | 0.029 | CYP1A2-substrate: | 0.198 |
| CYP2C19-inhibitor: | 0.042 | CYP2C19-substrate: | 0.107 |
| CYP2C9-inhibitor: | 0.501 | CYP2C9-substrate: | 0.984 |
| CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.129 |
| CYP3A4-inhibitor: | 0.102 | CYP3A4-substrate: | 0.095 |
| Clearance (CL): | 6.05 | Half-life (T1/2): | 0.927 |
| hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.418 |
| Drug-inuced Liver Injury (DILI): | 0.775 | AMES Toxicity: | 0.011 |
| Rat Oral Acute Toxicity: | 0.888 | Maximum Recommended Daily Dose: | 0.953 |
| Skin Sensitization: | 0.182 | Carcinogencity: | 0.847 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.018 |
| Respiratory Toxicity: | 0.125 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004421 | ![]() |
0.699 | D0X8KY | ![]() |
0.244 | ||
| ENC004419 | ![]() |
0.532 | D01WUA | ![]() |
0.235 | ||
| ENC002048 | ![]() |
0.453 | D02RQU | ![]() |
0.232 | ||
| ENC003570 | ![]() |
0.424 | D0K7HU | ![]() |
0.230 | ||
| ENC004420 | ![]() |
0.398 | D0ZI4H | ![]() |
0.219 | ||
| ENC002163 | ![]() |
0.380 | D0N3NO | ![]() |
0.218 | ||
| ENC004418 | ![]() |
0.371 | D06WTZ | ![]() |
0.217 | ||
| ENC002063 | ![]() |
0.361 | D0I4DQ | ![]() |
0.217 | ||
| ENC004295 | ![]() |
0.336 | D0V0IX | ![]() |
0.215 | ||
| ENC004121 | ![]() |
0.333 | D0M5OC | ![]() |
0.215 | ||